Zenas Biopharma Inc (ZBIO)

Nov 12, 2024, 7:10 AM EST - 2 months ago

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Nov 12, 2024, 7:05 AM EST - 2 months ago

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Nov 7, 2024, 7:05 AM EST - 2 months ago

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

Sep 19, 2024, 4:15 PM EDT - 4 months ago

Zenas BioPharma Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

Sep 14, 2024, 5:00 AM EDT - 4 months ago

U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market

BCAX GLXG MBX TDTH XCH

Sep 12, 2024, 10:37 PM EDT - 4 months ago

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

Sep 7, 2024, 1:25 AM EDT - 4 months ago

U.S. IPO Weekly Recap: 2 APAC Microcaps Go Public In Short Labor Day Week As The Pipeline Grows

BCAX BIOA PMAX PTHL

Aug 26, 2024, 11:11 AM EDT - 5 months ago

Zenas BioPharma Seeks IPO For Inflammatory Treatment Trials

Aug 24, 2024, 5:00 AM EDT - 5 months ago

U.S. IPO Weekly Recap: WeRide Delays Its IPO As Pipeline Gets A Boost

AZI RITR TDTH WOK

Aug 22, 2024, 3:55 PM EDT - 5 months ago

Immunology-focused biotech Zenas BioPharma files for an estimated $150 million IPO

Aug 22, 2024, 3:25 PM EDT - 5 months ago

Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO

Aug 22, 2024, 2:41 PM EDT - 5 months ago

Zenas BioPharma IPO Registration Document (S-1)